The value of immunotherapy in head and neck cancer Review

Manca, Paolo, Raez, Luis E, Salzberg, Matthew et al. (2019). The value of immunotherapy in head and neck cancer . Expert Opinion on Biological Therapy, 19(1), 35-43. 10.1080/14712598.2019.1556637

International Collaboration

cited authors

  • Manca, Paolo; Raez, Luis E; Salzberg, Matthew; Sanchez, Jorge; Hunis, Brian; Rolfo, Christian

sustainable development goals

authors

publication date

  • January 2, 2019

published in

keywords

  • Biotechnology & Applied Microbiology
  • CISPLATIN PLUS FLUOROURACIL
  • Checkpoint inhibitors
  • HPV
  • HUMAN-PAPILLOMAVIRUS
  • Head and neck cancer
  • Life Sciences & Biomedicine
  • MICROSATELLITE INSTABILITY
  • Medicine, Research & Experimental
  • OPEN-LABEL
  • P16
  • PD-1
  • PD-1 BLOCKADE
  • PD-L1
  • PHASE-II
  • RECURRENT
  • Research & Experimental Medicine
  • SINGLE-AGENT
  • SQUAMOUS-CELL CARCINOMA
  • Science & Technology
  • T-CELLS
  • squamous cell cancer

Digital Object Identifier (DOI)

start page

  • 35

end page

  • 43

volume

  • 19

issue

  • 1